• Sjögren’s syndrome (SS) is a chronic, autoimmune, systemic, inflammatory disorder of unknown cause.
• It is characterized by dryness of the mouth, eyes, and other mucous membranes due to lymphocytic infiltration of exocrine glands and secondary gland dysfunction.
• There is currently no cure for Sjögren’s syndrome, but there are treatments that can help relieve the symptoms.
• Based on the type, the market is segmented into primary Sjogren’s syndrome and secondary.
• Secondary Sjogren’s syndrome segment dominates the market.
• Geographically, the market is segmented into five major regions, namely North America, South America, Europe, Asia Pacific, and RoW.
• North America is the largest market for Sjögren’s syndrome owing to the rising prevalence of autoimmune diseases and advanced autoimmune diagnostic testing and screening.
Market Scope of the Report:
• The report also profiles companies in the Sjögren’s syndrome market – Novartis AG, Allergan Inc., Otsuka Pharmaceutical Co., Ltd., Santen Pharmaceutical Co., Ltd., Nicox S.A., Argentis Pharmaceuticals, LLC., Auven Therapeutics, Bridge Pharma Inc. and Cellzome GmbH.
By Drug Class
• Cholinergic Agonists
• Off-Label Drugs
By Type
• Primary Sjogren’s Syndrome
• Secondary Sjogren’s Syndrome
By Distribution Channel
• Hospitals
• Retail Pharmacy
• Online Pharmacy
By Region
• Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)
• Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)
• North America (The USA, Canada, Mexico)
• South America (Brazil, Argentina, Rest of South America)
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
